CITADEL ADVISORS LLC

Holdings History for Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE)

Symbol: SKYE on Nasdaq
Investment type: Equity / Common Stock, par value $0.001

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025			-0%	$0	0	-28,852	-100%	$0.72	Q4 2025
31 Dec 2025	call	0%	+0%	$48,506	64,700	+36,500	+129%	$0.75	Q4 2025
31 Dec 2025	put	0%	+0%	$13,495	18,000	+18,000	NEW	$0.75	Q4 2025
30 Sep 2025		0%	+0%	$113,388	28,852	+28,852	NEW	$3.93	Q3 2025
30 Sep 2025	call	0%	-0%	$110,826	28,200	-5,200	-16%	$3.93	Q3 2025
30 Sep 2025	put		-0%	$0	0	-16,700	-100%	$0.72	Q3 2025
30 Jun 2025	call	0%	+0%	$139,612	33,400	+33,400	NEW	$4.18	Q2 2025
30 Jun 2025	put	0%	+0%	$69,806	16,700	+16,700	NEW	$4.18	Q2 2025
31 Mar 2025			-0%	$0	0	-250,014	-100%	$0.72	Q1 2025
31 Mar 2025	call		0%	$0	0	-100	-100%	$0.72	Q1 2025
31 Dec 2024		0%	0%	$707,540	250,014	+1	+0%	$2.83	Q4 2024
31 Dec 2024	call	0%	-0%	$283	100	-8,000	-99%	$2.83	Q4 2024
31 Dec 2024	put		-0%	$0	0	-15,200	-100%	$0.72	Q4 2024
30 Sep 2024		0%	-0%	$977,551	250,013	-15,574	-5.9%	$3.91	Q3 2024
30 Sep 2024	call	0%	+0%	$31,671	8,100	+7,000	+636%	$3.91	Q3 2024
30 Sep 2024	put	0%	+0%	$59,432	15,200	+14,100	+1282%	$3.91	Q3 2024
30 Jun 2024		0%	+0%	$2,127,352	265,587	+265,587	NEW	$8.01	Q2 2024
30 Jun 2024	call	0%	+0%	$8,811	1,100	+1,100	NEW	$8.01	Q2 2024
30 Jun 2024	put	0%	+0%	$8,811	1,100	+1,100	NEW	$8.01	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.